LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363. [electronic resource]
Producer: 20191125Description: 3238-3245 p. digitalISSN:- 1582-4934
- Carcinoma, Hepatocellular -- drug therapy
- Cell Movement -- genetics
- Cell Proliferation -- genetics
- Drug Resistance, Neoplasm -- genetics
- Gene Expression Regulation, Neoplastic
- Hep G2 Cells
- Heterografts
- Humans
- Liver Neoplasms -- drug therapy
- MicroRNAs -- genetics
- Multidrug Resistance-Associated Proteins -- genetics
- Neoplasm Invasiveness -- genetics
- Oxaliplatin -- administration & dosage
- RNA, Long Noncoding -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.